DiaMedica Therapeutics Growth Metrics (2018-2019) | DMAC

Growth Metrics Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019
Growth Ratios
Assets (QoQ) -15.51%-17.41%-13.74%
Capital Expenditures Growth (1y) 207.69%
Capital Expenditures (QoQ) -68.75%110.00%-161.90%
Cash & Equivalents Growth (1y) -58.88%-48.06%21.63%
Cash & Equivalents (QoQ) -14.66%-31.92%331.58%-83.60%7.79%59.41%
Cash from Investing Activities Growth (1y) -34,050.00%30,220.00%14,385.71%7,653.85%
Cash from Investing Activities (QoQ) 68.75%-110.00%161.90%-84,161.54%127.56%-0.40%-66.40%
Cash from Operations Growth (1y) -235.19%-180.65%32.97%1.84%
Cash from Operations (QoQ) -9.41%-79.67%-3.37%-64.95%8.39%57.09%-51.38%
EBIT Growth (1y) -161.94%-48.16%-78.95%-30.85%
EBIT (QoQ) -41.65%19.62%-42.37%-61.60%19.88%2.92%-4.10%
EBT Growth (1y) -399.69%-43.16%-83.16%-26.69%
EBT (QoQ) -164.87%22.63%-47.07%-65.80%24.11%1.02%-1.72%
Enterprise Value Growth (1y) 430.16%634.02%958.95%45.06%
Enterprise Value (QoQ) 14.66%31.92%677.61%-1.61%38.03%9.50%-2.45%
EPS (Basic) Growth (1y) -170.00%4.55%-11.11%8.70%
EPS (Basic) (QoQ) -120.00%18.18%-27.78%-17.39%22.22%4.76%-5.00%
Free Cash Flow Growth (1y) -224.10%-177.93%33.73%0.42%
Free Cash Flow (QoQ) -6.83%-79.96%-1.51%-66.08%8.39%57.09%-52.52%
Net Cash Flow Growth (1y) -362.54%121.85%196.66%-106.64%
Net Cash Flow (QoQ) -118.37%-85.77%807.06%-208.81%101.53%721.86%-148.56%
Net Income Growth (1y) -400.31%-42.31%-76.50%-26.40%
Net Income (QoQ) -166.92%20.06%-41.46%-65.75%24.08%0.85%-1.31%
Net Income towards Common Stockholders Growth (1y) -400.31%-42.31%-76.50%-26.40%
Net Income towards Common Stockholders (QoQ) -166.92%20.06%-41.46%-65.75%24.08%0.85%-1.31%
Operating Income Growth (1y) -161.94%-48.16%-78.95%-30.85%
Operating Income (QoQ) -41.65%19.62%-42.37%-61.60%19.88%2.92%-4.10%
Profit After Tax Growth (1y) -400.31%-42.31%-76.50%-26.40%
Profit After Tax (QoQ) -166.92%20.06%-41.46%-65.75%24.08%0.85%-1.31%
Property, Plant & Equipment (Net) (QoQ) -6.25%-18.89%-6.85%
Return on Assets (QoQ) -15.00-21.00
Return on Capital Employed (QoQ) -17.00-28.00
Return on Equity (QoQ) 0.00-17.00-24.00
Share-based Compensation Growth (1y) -15.03%-37.67%310.00%516.92%
Share-based Compensation (QoQ) 90.85%-62.33%-40.91%100.00%40.00%147.80%-11.09%
Shareholder's Equity Growth (1y) 106.08%118.52%136.01%
Shareholder's Equity (QoQ) -20.64%-23.25%314.23%-18.32%-15.85%-17.11%